Ignite Creation Date:
2024-05-06 @ 4:04 AM
Last Modification Date:
2024-10-26 @ 11:43 AM
Study NCT ID:
NCT02441946
Status:
COMPLETED
Last Update Posted:
2020-06-17
First Post:
2015-05-08
Brief Title:
A Neoadjuvant Study of Abemaciclib LY2835219 in Postmenopausal Women With Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor:
Organization:
Eli Lilly and Company